Global Oxytocic Pharmaceuticals Market: Overview
Dubbed the “love hormone,” oxytocin is a female reproductive hormone, produced in the hypothalamus and released into bloodstream during childbirth. This hormone induces labor and milk production in a lactating mother. Oxytocic drugs can be used as uterotonic for induced labor and to reduce the chances of hemorrhage post C-section. Besides this, oxytocic drugs are also administered in conditions such as post-mature birth; uterine atony; pre-eclampsia, which means hypertension during pregnancy; stillbirth; postpartum hemorrhage; and as an adjunct therapy for treatment of autism and in cases of incomplete abortion.
Apart from being administered to humans, oxytocic drugs are also used as veterinary medications. Oxytocin demonstrates its effect after delivery, during childbirth, and toward the end stage of pregnancy.
According to the World Health Organization, every year more than 15 million babies are born prematurely, and this number of preterm births is expected to increase in the coming years. As per the findings of the National Center for Health Statistics, the U.S. alone exhibited a 23.3% labor induction rate in 2012. Considering these statistics, the demand for oxytocic drugs is expected increase significantly in the near future.
The report provides a comprehensive overview of the global oxytocic pharmaceuticals market. It presents insights into the factors influencing the market’s trajectory. The impact of the prevailing demand and supply trends on the market operations is also examined in the report in detail.
Global Oxytocic Pharmaceuticals Market: Key Opportunities and Threats
The increasing incidence of preterm births and the rising rates of labor induction are the primary factors fuelling demand from the global oxytocic pharmaceuticals market. The rising cases of pregnancy-related complications emerging in developing nations also translate into the increased use of oxytocic drugs. Additionally, the market is also expected to gain from the expansion of the health care and pharmaceutical industries in developing countries. However, awareness regarding the side effects related to oxytocic drugs can hamper their use to an extent, thereby restraining the global oxytocic pharmaceuticals market.
Leading brands offer numerous oxytocic products. Pitocin, Octocin, Evatocin, Syntocinon, Pitogin, Duratocin, Cytotec, and Tiacinon are the most popular brands competing for a larger share of the global oxytocic market. However, the synthetic oxytocin derivatives segment is poised to hold the largest share in the market owing to its easy availability. Likewise, hospitals are expected to emerge as the major end-use sector in the market.
Global Oxytocic Pharmaceuticals Market: Region-wise Outlook
Regionally, North America has been exhibiting the highest demand for oxytocic pharmaceuticals due to the high prevalence of induced labor in the region. Europe is expected to emerge as the second-largest market for oxytocic pharmaceuticals due to the rise in oxytocin administration in response to the increasing number of elective caesareans. The market is also anticipated to gain from the increasing case of C-sections in countries in Asia Pacific, such as India and China.
Global Oxytocic Pharmaceuticals Market: Vendor Landscape
To study the prevailing competitive landscape of the market, the report profiles companies such as APP Pharmaceuticals, LLC, LBS Labs, Baxter Healthcare Corporation, JHP Pharmaceuticals, LLC, and Pfizer Inc. The report studies these companies based on their business strategies, financial overview, and product portfolio. The strengths and weaknesses of these enterprises are analyzed. The report also presents in-depth overview of the threats and opportunities that these companies are expected to face during the forecast period.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, Luxembourg)
- Eastern Europe (Poland, Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia and New Zealand)
- Middle East and Africa (GCC, Southern Africa, North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.